Aytekin Oto to Prostate
This is a "connection" page, showing publications Aytekin Oto has written about Prostate.
Connection Strength
10.388
-
Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging. Abdom Radiol (NY). 2022 07; 47(7):2500-2508.
Score: 0.633
-
Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI. Radiology. 2022 06; 303(3):588-589.
Score: 0.624
-
Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. Abdom Radiol (NY). 2022 02; 47(2):801-813.
Score: 0.614
-
Navigating the Challenges of Targeting Accuracy and Tumor Heterogeneity in Targeted Prostate Biopsy. Radiology. 2019 Apr; 291(1):90-91.
Score: 0.503
-
Multiparametric MR imaging of the Prostate: Pitfalls in Interpretation. Radiol Clin North Am. 2018 Mar; 56(2):277-287.
Score: 0.466
-
Prostate MR Imaging. Radiol Clin North Am. 2018 03; 56(2):xiii.
Score: 0.466
-
MR Imaging of Prostate Zonal Anatomy. Radiol Clin North Am. 2018 Mar; 56(2):197-209.
Score: 0.465
-
MRI-based prostate cancer detection with high-level representation and hierarchical classification. Med Phys. 2017 Mar; 44(3):1028-1039.
Score: 0.441
-
Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study. AJR Am J Roentgenol. 2016 Mar; 206(3):559-65.
Score: 0.411
-
Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation. Radiographics. 2016 Jan-Feb; 36(1):162-75.
Score: 0.403
-
Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate. Abdom Imaging. 2015 Oct; 40(7):2523-8.
Score: 0.400
-
IV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model. AJR Am J Roentgenol. 2015 Sep; 205(3):W313-9.
Score: 0.397
-
Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone? Radiology. 2015 May; 275(2):448-57.
Score: 0.380
-
Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate. Acad Radiol. 2014 May; 21(5):569-77.
Score: 0.362
-
MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation. Radiology. 2014 May; 271(2):452-60.
Score: 0.356
-
Revisiting the central gland anatomy via MRI: does the central gland extend below the level of verumontanum? J Magn Reson Imaging. 2014 Jan; 39(1):167-71.
Score: 0.348
-
Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):378-84.
Score: 0.318
-
High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique. J Magn Reson Imaging. 2011 Oct; 34(4):956-61.
Score: 0.303
-
Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer. Top Magn Reson Imaging. 2009 Apr; 20(2):105-12.
Score: 0.255
-
Self-supervised multicontrast super-resolution for diffusion-weighted prostate MRI. Magn Reson Med. 2024 Jul; 92(1):319-331.
Score: 0.178
-
Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard tofts model in the diagnosis of prostate cancer. Phys Eng Sci Med. 2023 Sep; 46(3):1215-1226.
Score: 0.171
-
An Interactive App with Multi-parametric MRI - Whole-Mount Histology Correlation for Enhanced Prostate MRI Training of Radiology Residents. Acad Radiol. 2023 09; 30 Suppl 1:S21-S29.
Score: 0.169
-
Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer? Acad Radiol. 2022 07; 29(7):977-985.
Score: 0.152
-
Future Perspectives in Multiparametric Prostate MR Imaging. Magn Reson Imaging Clin N Am. 2019 Feb; 27(1):117-130.
Score: 0.126
-
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging. Eur Urol Oncol. 2019 05; 2(3):257-264.
Score: 0.125
-
MR Imaging-Guided Focal Therapies of Prostate Cancer. Magn Reson Imaging Clin N Am. 2019 Feb; 27(1):131-138.
Score: 0.124
-
A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification. JAMA Oncol. 2018 05 01; 4(5):678-685.
Score: 0.120
-
Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study. Radiology. 2018 06; 287(3):864-873.
Score: 0.118
-
Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction. Am J Pathol. 2017 Nov; 187(11):2378-2387.
Score: 0.114
-
Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer. J Urol. 2016 12; 196(6):1670-1675.
Score: 0.106
-
Deformable segmentation of 3D MR prostate images via distributed discriminative dictionary and ensemble learning. Med Phys. 2014 Jul; 41(7):072303.
Score: 0.092
-
MR imaging of the prostate. Radiol Clin North Am. 2014 Jul; 52(4):811-37.
Score: 0.090
-
Hybrid multidimensional T(2) and diffusion-weighted MRI for prostate cancer detection. J Magn Reson Imaging. 2014 Apr; 39(4):781-8.
Score: 0.086
-
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol. 2013 Oct; 64(4):544-52.
Score: 0.084
-
Four-quadrant vector mapping of hybrid multidimensional MRI data for the diagnosis of prostate cancer. Med Phys. 2024 Mar; 51(3):2057-2065.
Score: 0.043
-
Improving reader accuracy and specificity with the addition of hybrid multidimensional-MRI to multiparametric-MRI in diagnosing clinically significant prostate cancers. Abdom Radiol (NY). 2023 10; 48(10):3216-3228.
Score: 0.043
-
Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion. Magn Reson Med. 2022 11; 88(5):2298-2310.
Score: 0.040
-
Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings. Radiology. 2022 02; 302(2):368-377.
Score: 0.038
-
MRI Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2021 12; 217(6):1263-1281.
Score: 0.037
-
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021 12; 4(6):868-876.
Score: 0.036
-
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020 07; 296(1):76-84.
Score: 0.034
-
Use of Indicator Dilution Principle to Evaluate Accuracy of Arterial Input Function Measured With Low-Dose Ultrafast Prostate Dynamic Contrast-Enhanced MRI. Tomography. 2019 06; 5(2):260-265.
Score: 0.032
-
Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis. Invest Radiol. 2018 10; 53(10):609-615.
Score: 0.031
-
The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology. 2017 11; 285(2):343-356.
Score: 0.029
-
In vivo MRI based prostate cancer localization with random forests and auto-context model. Comput Med Imaging Graph. 2016 09; 52:44-57.
Score: 0.026